| Literature DB >> 28491632 |
Nael Aldweib1, Emerson H Liu1, Amresh Raina1, Indu Poornima1, Amit J Thosani1.
Abstract
Entities:
Keywords: 18F-FDG, fluorine-18-fluorodeoxyglucose; CMR, cardiovascular magnetic resonance imaging; Cardiac sarcoidosis; Computed tomography (CT); ECG, electrocardiogram; Fluorine-18-fluorodeoxyglucose (18F-FDG); LV, left ventricular; PET-CT, positron emission tomography–computed tomography; Positron emission tomography (PET); Sinus node dysfunction
Year: 2015 PMID: 28491632 PMCID: PMC5412661 DOI: 10.1016/j.hrcr.2015.09.007
Source DB: PubMed Journal: HeartRhythm Case Rep ISSN: 2214-0271
Figure 1A: An electrocardiogram recorded at presentation. B: An electrocardiogram recorded 2 months after initial presentation shows progressive conduction system disease with PR prolongation and new left anterior hemiblock.
Figure 2A repeat cardiac magnetic resonance image, which was taken 2 months after cardiac magnetic resonance imaging with normal results, shows a small inferior delayed hyperenhancement.
Figure 3A: Normal technetium-99m sestamibi rest-and-stress perfusion image. B: Result of a cardiac fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography scan. Fluorine-18-fluorodeoxyglucose uptake is present in the right atrium, septum, and lateral left ventricle. C: Repeat image that was taken after 3 months of steroid therapy. VLA = vertical long axis; HLA = horizontal long axis; APX: = apex; INF = inferior; LAT = lateral; BAS = basal; SEP = septal.
KEY TEACHING POINTS
Sinus node dysfunction is an uncommon presentation for cardiac sarcoidosis. Cardiac magnetic resonance imaging, despite proven utility in evaluation for cardiac sarcoidosis, may not be sufficiently sensitive to detect the early stages of the disease. Results of a fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography scan may highlight areas of cardiac inflammation that correlate with clinical disease activity, identify nonenlarged mediastinal lymph nodes suitable for biopsy, and help determine response to steroid therapy. |